Cycad Group

CDTI and CSI merged in December 2010.

#Emissions Control

The Seraph 100 blood filter received CE Mark approval in the EU in 2019 and is available for the treatment of COVID-19 in the US under an FDA Emergency Use Authorization.

#Medical Devices

MacLean Fogg has acquired Formetrix Metal’s proprietary, high performance steel alloy powders for additive manufacturing.

#3D Printing

FzioMed’s product platform is an innovative polymer technology called Oxiplex® for the prevention of post-surgical adhesions.

#Biosurgery

Genocea uses its proprietary technology platform, ATLAS™, to develop neoantigen cancer vaccines.

#Biotechnology

GRT has licensed certain of its key technologies to Marathon Oil Corporation.

#Energy

ImaginAb’s technology enables antibodies to be re-engineered into smaller proteins for diagnostic imaging.

#Diagnostics

Intarcia is developing therapies utilizing its Medici Drug Delivery System™ to target Type 2 Diabetes.

#Biotechnology

Lixivia applies proprietary processes to improve the recovery of minerals from industrial waste products.

#Materials

OvaScience merged with Millendo Therapeutics.

#Biotechnology

Sirtris has been acquired by GlaxoSmithKline.

#Pharmaceuticals

Sofie combines novel tools for PET imaging and radiosynthesis with a full line of imaging and radiochemistry systems.

#Imaging

Solaria manufactures low-concentration photovoltaic modules for ground-mounted tracking systems.

#Renewable Energy

SteriFx was acquired in a private transaction.

#Chemicals

U.S. Steel has acquired Nanosteel’s advanced sheet steel intellectual property and trademarks.

#Materials

TPX is focused on oil and gas exploration and development in the Arkoma Basin of southeastern Oklahoma.

#Oil and Gas

Unity focuses on developing therapeutics that extend the human healthspan through intervention in the biological mechanisms associated with aging.

#Biotechnology